262 related articles for article (PubMed ID: 25684642)
1. Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.
Feinstein MJ; Jhund P; Kang J; Ning H; Maggioni A; Wikstrand J; Kjekshus J; Tavazzi L; McMurray J; Lloyd-Jones DM
Eur J Heart Fail; 2015 Apr; 17(4):434-41. PubMed ID: 25684642
[TBL] [Abstract][Full Text] [Related]
2. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
Latini R; Gullestad L; Masson S; Nymo SH; Ueland T; Cuccovillo I; Vårdal M; Bottazzi B; Mantovani A; Lucci D; Masuda N; Sudo Y; Wikstrand J; Tognoni G; Aukrust P; Tavazzi L;
Eur J Heart Fail; 2012 Sep; 14(9):992-9. PubMed ID: 22740508
[TBL] [Abstract][Full Text] [Related]
3. Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial.
Rossi A; Inciardi RM; Rossi A; Temporelli PL; Lucci D; Gonzini L; Marchioli R; Nicolosi GL; Tavazzi L;
Pulm Pharmacol Ther; 2017 Jun; 44():16-23. PubMed ID: 28263812
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Gullestad L; Ueland T; Kjekshus J; Nymo SH; Hulthe J; Muntendam P; Adourian A; Böhm M; van Veldhuisen DJ; Komajda M; Cleland JG; Wikstrand J; McMurray JJ; Aukrust P;
Eur Heart J; 2012 Sep; 33(18):2290-6. PubMed ID: 22513778
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Cleland JG; McMurray JJ; Kjekshus J; Cornel JH; Dunselman P; Fonseca C; Hjalmarson A; Korewicki J; Lindberg M; Ranjith N; van Veldhuisen DJ; Waagstein F; Wedel H; Wikstrand J;
J Am Coll Cardiol; 2009 Nov; 54(20):1850-9. PubMed ID: 19892235
[TBL] [Abstract][Full Text] [Related]
6. Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
McMurray JJ; Kjekshus J; Gullestad L; Dunselman P; Hjalmarson A; Wedel H; Lindberg M; Waagstein F; Grande P; Hradec J; Kamenský G; Korewicki J; Kuusi T; Mach F; Ranjith N; Wikstrand J;
Circulation; 2009 Dec; 120(22):2188-96. PubMed ID: 19917888
[TBL] [Abstract][Full Text] [Related]
7. [To treat or not to treat with statins patients with chronic heart failure?].
Hradec J
Vnitr Lek; 2009 Sep; 55(9):802-7. PubMed ID: 19785380
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin in older patients with systolic heart failure.
Kjekshus J; Apetrei E; Barrios V; Böhm M; Cleland JG; Cornel JH; Dunselman P; Fonseca C; Goudev A; Grande P; Gullestad L; Hjalmarson A; Hradec J; Jánosi A; Kamenský G; Komajda M; Korewicki J; Kuusi T; Mach F; Mareev V; McMurray JJ; Ranjith N; Schaufelberger M; Vanhaecke J; van Veldhuisen DJ; Waagstein F; Wedel H; Wikstrand J;
N Engl J Med; 2007 Nov; 357(22):2248-61. PubMed ID: 17984166
[TBL] [Abstract][Full Text] [Related]
9. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
Tavazzi L; Maggioni AP; Marchioli R; Barlera S; Franzosi MG; Latini R; Lucci D; Nicolosi GL; Porcu M; Tognoni G;
Lancet; 2008 Oct; 372(9645):1231-9. PubMed ID: 18757089
[TBL] [Abstract][Full Text] [Related]
10. Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.
Ghio S; Scelsi L; Latini R; Masson S; Eleuteri E; Palvarini M; Vriz O; Pasotti M; Gorini M; Marchioli R; Maggioni A; Tavazzi L;
Eur J Heart Fail; 2010 Dec; 12(12):1345-53. PubMed ID: 20952767
[TBL] [Abstract][Full Text] [Related]
11. Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Askevold ET; Gullestad L; Nymo S; Kjekshus J; Yndestad A; Latini R; Cleland JG; McMurray JJ; Aukrust P; Ueland T
PLoS One; 2015; 10(8):e0133970. PubMed ID: 26288364
[TBL] [Abstract][Full Text] [Related]
12. Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA).
Haver VG; Mateo Leach I; Kjekshus J; Fox JC; Wedel H; Wikstrand J; de Boer RA; van Gilst WH; McMurray JJ; van Veldhuisen DJ; van der Harst P
Eur J Heart Fail; 2015 Mar; 17(3):313-9. PubMed ID: 25639660
[TBL] [Abstract][Full Text] [Related]
13. Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Rogers JK; Jhund PS; Perez AC; Böhm M; Cleland JG; Gullestad L; Kjekshus J; van Veldhuisen DJ; Wikstrand J; Wedel H; McMurray JJ; Pocock SJ
JACC Heart Fail; 2014 Jun; 2(3):289-97. PubMed ID: 24952697
[TBL] [Abstract][Full Text] [Related]
14. Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA).
Arain F; Gullestad L; Nymo S; Kjekshus J; Cleland JG; Michelsen A; McMurray JJ; Wikstrand J; Aukrust P; Ueland T
Biomarkers; 2017; 22(3-4):261-267. PubMed ID: 27325138
[TBL] [Abstract][Full Text] [Related]
15. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure.
Lipinski MJ; Cauthen CA; Biondi-Zoccai GG; Abbate A; Vrtovec B; Khan BV; Vetrovec GW
Am J Cardiol; 2009 Dec; 104(12):1708-16. PubMed ID: 19962481
[TBL] [Abstract][Full Text] [Related]
17. Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ; ;
Circulation; 2015 Apr; 131(17):1486-94; discussion 1494. PubMed ID: 25810334
[TBL] [Abstract][Full Text] [Related]
18. Lipophilic Statin Versus Rosuvastatin (Hydrophilic) Treatment for Heart Failure: a Meta-Analysis and Adjusted Indirect Comparison of Randomised Trials.
Bonsu KO; Reidpath DD; Kadirvelu A
Cardiovasc Drugs Ther; 2016 Apr; 30(2):177-88. PubMed ID: 26780905
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical outcome trials of statins in heart failure.
Fonarow GC
Heart Fail Clin; 2008 Apr; 4(2):225-9. PubMed ID: 18433703
[TBL] [Abstract][Full Text] [Related]
20. Relation of statin therapy to risk of heart failure after acute myocardial infarction.
Aronson D; Mutlak D; Lessick J; Kapeliovich M; Dabbah S; Markiewicz W; Beyar R; Hammerman H; Reisner S; Agmon Y
Am J Cardiol; 2008 Dec; 102(12):1706-10. PubMed ID: 19064028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
